Skip to main content

Alector Inc

For the period ended Dec 31, 2024. Filed Feb 26, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 26, 2025

ALEC$2.46+7.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

ALECTOR, INC.
Date: February 26, 2025By:/s/ Arnon Rosenthal
Arnon Rosenthal, Ph.D.
Co-founder and Chief Executive Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Arnon Rosenthal, Ph.D., Sara Kenkare-Mitra, Ph.D., and Marc Grasso, M.D. as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and substitution, for him or her and in his or her name, place, and stead, in any and all capacities (including his capacity as a director and/or officer of Alector, Inc.) to sign any or all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as they, he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agents or any of them, or their, his, or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Arnon Rosenthal Arnon Rosenthal, Ph.D.Co-founder, Chief Executive Officer, and Director(Principal Executive Officer)February 26, 2025
/s/ Marc Grasso Marc Grasso, M.D.Chief Financial Officer(Principal Financial and Accounting Officer)February 26, 2025
/s/ Lou J. Lavigne, Jr. Louis J. Lavigne, Jr.Chairperson of the BoardFebruary 26, 2025
/s/ Elizabeth Garofalo Elizabeth Garofalo, M.D.DirectorFebruary 26, 2025
/s/ Paula Hammond Paula Hammond, Ph.D.DirectorFebruary 26, 2025
/s/ Mark Altmeyer Mark AltmeyerDirectorFebruary 26, 2025
/s/ Richard Scheller Richard Scheller, Ph.D.DirectorFebruary 26, 2025
/s/ David Wehner David WehnerDirectorFebruary 26, 2025
/s/ Kristine Yaffe Kristine Yaffe, M.D.DirectorFebruary 26, 2025
/s/ Errol De Souza Errol De Souza, Ph.D.DirectorFebruary 26, 2025
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.